1. PHS-2 Rapid Deployment Force, and Safety/Risk Communication Team Analyst, Office of Communications, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, MD. CAPT (RET.)
2. Clinical Investigations Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD
3. Division of Bioresearch Monitoring, Center for Devices and Radiological Health, FDA; at the time of writing he was Deputy Team Leader and Planning Section Chief, PHS-1 Rapid Deployment Force, CDER, FDA
4. PHS-1 Rapid Deployment Force, and Senior Clinical Analyst, Division of Biologic Oncology Products, Office of New Drugs, CDER, FDA. CAPT
5. PHS-2 Rapid Deployment Force, CDER, and Supervisory Investigator, Office of Regulatory Affairs, FDA